{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:04:52Z","timestamp":1791644692970,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.clinthera.2021.12.008","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T08:27:31Z","timestamp":1641457651000},"page":"295-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy of Intravenous Immunoglobulin Therapy for Patients With Sepsis and Low Immunoglobulin G Levels: A Single-Center Retrospective Study"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0065-9721","authenticated-orcid":false,"given":"Masayuki","family":"Akatsuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9635-9098","authenticated-orcid":false,"given":"Yoshiki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9688-6154","authenticated-orcid":false,"given":"Hiroomi","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7045-839X","authenticated-orcid":false,"given":"Tomoko","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.12.008_bib0001","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000102071","article-title":"Classification, incidence, and outcomes of sepsis and multiple organ failure","volume":"156","author":"Vincent","year":"2007","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1469-0691.2003.00694.x","article-title":"Intravenous immunoglobulins in infectious diseases: Where do we stand?","volume":"9","author":"Mouthon","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0004","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.clinthera.2019.06.010","article-title":"Evaluation of the effect of intravenous immunoglobulin dosing on mortality in patients with sepsis: a network meta-analysis","volume":"41","author":"Yang","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.shk.0000157302.69125.f8","article-title":"Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery","volume":"23","author":"Rodr\u00edguez","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0006","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jinf.2015.04.003","article-title":"Intravenous immunoglobulin use in septic shock patients after emergency laparotomy","volume":"71","author":"Tagami","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cid\/civ307","article-title":"Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study","volume":"61","author":"Tagami","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0008","first-page":"2693","article-title":"Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study","volume":"35","author":"Werdan","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0009","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","volume":"2013","author":"Alejandria","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0010","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.intimp.2011.08.024","article-title":"Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients","volume":"11","author":"Venet","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0011","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/SHK.0b013e3181a2c0b2","article-title":"Gamma-globulin levels in patients with community-acquired septic shock","volume":"32","author":"Taccone","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0012","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jmii.2020.08.013","article-title":"Low immunoglobulin G level is associated with poor outcomes in patients with sepsis and septic shock","volume":"54","author":"Akatsuka","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0013","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0014","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0015","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0016","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0017","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1526-0968.2001.005002115.x","article-title":"Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins","volume":"5","author":"Werdan","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0018","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00134-015-3845-7","article-title":"Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis","volume":"41","author":"Shankar-Hari","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0019","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/joim.12265","article-title":"Immunoglobulins IgG1, IgM and IgA: A synergistic team influencing survival in sepsis","volume":"276","author":"Bermejo-Mart\u00edn","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood-2002-01-0128","article-title":"Influence of plasma immunoglobulin level on antibody synthesis","volume":"100","author":"Goldammer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0021","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-3083.2009.02338.x","article-title":"Structural difference in the complement activation site of human IgG1 and IgG3","volume":"70","author":"Michaelsen","year":"2009","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0022","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1084\/jem.20120325","article-title":"Antibody orientation at bacterial surfaces is related to invasive infection","volume":"209","author":"Nordenfelt","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0023","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMcibr1007320","article-title":"Sepsis and endothelial permeability","volume":"363","author":"Lee","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2021.12.008_bib0024","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821005014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821005014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:56:07Z","timestamp":1758963367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291821005014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0149291821005014"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.12.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Intravenous Immunoglobulin Therapy for Patients With Sepsis and Low Immunoglobulin G Levels: A Single-Center Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}